Related Experiment Video
Updated: Mar 2, 2026
09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
4.7K
Epstein-Barr virus and rheumatoid arthritis
Nathalie Balandraud1, Jean Roudier1
1Rheumatology 1, IML, AP-HM, 270, boulevard de Sainte-Marguerite, 13009 Marseille, France; Inserm UMRs 1097, Aix-Marseille University, 163, avenue de Luminy, 13288 Marseille, France.
Joint Bone Spine
|May 14, 2017
Summary
Rheumatoid arthritis patients show poor control of Epstein-Barr virus (EBV) infection, with higher EBV loads and increased risk of EBV-associated cancers. This suggests EBV may play a role in rheumatoid arthritis development.
Area of Science:
- Immunology
- Virology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a prevalent autoimmune disease with unknown etiology.
- Genetic and environmental factors, including Epstein-Barr virus (EBV), are implicated in RA pathogenesis.
- EBV is a widespread herpesvirus known to establish lifelong infections.
Purpose of the Study:
- To explore the relationship between EBV and rheumatoid arthritis.
- To investigate EBV infection control in RA patients.
- To assess the risk of EBV-associated lymphoproliferative disorders in RA.
Main Methods:
- Review of existing literature on EBV and RA.
- Analysis of antibody titers against EBV antigens in RA patients.
- Comparison of EBV-infected B cell counts in RA patients versus controls.
- Evaluation of T lymphocyte function in controlling EBV-infected B cells.
Main Results:
- RA patients exhibit impaired control of EBV infection.
- Elevated antibody titers against EBV antigens are observed in RA patients.
- RA patients harbor more EBV-infected B cells, leading to a significant systemic EBV overload.
- RA patients have an increased risk of developing EBV-associated lymphoproliferative disorders.
Conclusions:
- EBV infection control is compromised in rheumatoid arthritis.
- The heightened EBV load and associated risks suggest EBV's role in RA pathogenesis.
- Monitoring EBV load is crucial for RA patients undergoing immunosuppressive therapy.
- Anti-EBV antibody responses may contribute to chronic autoimmunity in RA.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
656
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
656
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
793
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
793
01:24T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
01:20The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K